Investing.com - Transphorm Tech (NASDAQ: TGAN) reported second quarter EPS of $-0.13, $0.02 worse than the analyst estimate of $-0.11. Revenue for the quarter came in at $3.19M versus the consensus estimate of $4.67M.
Transphorm Tech's stock price closed at $3.73. It is down -6.52% in the last 3 months and down -17.48% in the last 12 months.
Transphorm Tech saw 0 positive EPS revisions and 3 negative EPS revisions in the last 90 days. See Transphorm Tech's stock price’s past reactions to earnings here.
According to InvestingPro, Transphorm Tech's Financial Health score is "weak performance".
Check out Transphorm Tech's recent earnings performance, and Transphorm Tech's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar